Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03506503 |
Recruitment Status :
Completed
First Posted : April 24, 2018
Last Update Posted : February 21, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Androgenic Alopecia | Procedure: Nanofat grafting | Not Applicable |
The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up.
Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 10 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia |
Actual Study Start Date : | February 27, 2019 |
Actual Primary Completion Date : | February 27, 2020 |
Actual Study Completion Date : | May 1, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: processed Nanofat grafting
processed autologous Nanofat will be injected into the area of the scalp with androgenic alopecia.
|
Procedure: Nanofat grafting
hair loss area will be treated by processed autologous Nanofat grafting |
- Dermatoscope [ Time Frame: Baseline and at1,3,6,9,12 months after the treatment ]the density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting.
- Satisfaction assessments [ Time Frame: 1,3,6,12 months after treatment ]the satisfaction will be assessed after the treatment

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male patients with androgenic alopecia aging from 18 to 50.
- No scars and wounds on the alopecia area.
- No skin disease or serious cardiovascular disease.
- Preoperative examinations remain healthy.
Exclusion Criteria:
- Serious chronic heart, liver, kidney, blood system disease
- Allergic diseases, skin inflammation or wounds
- Alopecia but not androgenic alopecia
- Acute or chronic infection
- Take anticoagulant drugs
- Active vitiligo, psoriasis, systemic lupus erythematosus

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03506503
China, Guangdong | |
the first affiliated hospital of Jinan University | |
Guangzhou, Guangdong, China, 510000 |
Responsible Party: | Hongwei Liu, professor, Jinan University Guangzhou |
ClinicalTrials.gov Identifier: | NCT03506503 |
Other Study ID Numbers: |
2019004 |
First Posted: | April 24, 2018 Key Record Dates |
Last Update Posted: | February 21, 2021 |
Last Verified: | February 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
nanofat hair loss prp |
Alopecia Alopecia Areata Hypotrichosis |
Hair Diseases Skin Diseases Pathological Conditions, Anatomical |